Lipocine (LPCN)
(Real Time Quote from BATS)
$4.77 USD
-0.03 (-0.58%)
Updated Apr 29, 2024 03:32 PM ET
4-Sell of 5 4
F Value C Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/9/24 |
---|---|
Current Quarter | NA |
EPS Last Quarter | -0.42 |
Last EPS Surprise | 20.75% |
ABR | 1.00 |
Earnings ESP
|
NA |
---|---|
Current Year | -1.49 |
Next Year | NA |
EPS (TTM) | -3.05 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.06M | 0.00M | 0.50M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | -1.49 | NA |
# of Estimates | NA | NA | 1 | NA |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | NA | NA | -1.49 | NA |
Low Estimate | NA | NA | -1.49 | NA |
Year ago EPS | -0.68 | -0.68 | -3.14 | -1.49 |
Year over Year Growth Est. | NA | NA | 52.55% | NA |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | NA | NA | 0 | NA |
Up Last 30 Days | NA | NA | 0 | NA |
Up Last 60 Days | NA | NA | 0 | NA |
Down Last 7 Days | NA | NA | 0 | NA |
Down Last 30 Days | NA | NA | 0 | NA |
Down Last 60 Days | NA | NA | 1 | NA |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | NA | NA | -1.49 | NA |
7 Days Ago | NA | NA | -1.49 | NA |
30 Days Ago | NA | NA | -1.49 | NA |
60 Days Ago | NA | NA | -1.61 | -2.06 |
90 Days Ago | NA | NA | -1.61 | -2.06 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | NA | NA | -1.49 | NA |
Zacks Consensus Estimate | NA | NA | -1.49 | NA |
Earnings ESP | NA | NA | 0.00% | NA |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.42 | -1.27 | -0.68 | -0.68 | NA |
Estimate | -0.53 | -0.57 | -0.64 | NA | NA |
Difference | 0.11 | -0.70 | -0.04 | NA | -0.21 |
Surprise | 20.75% | -122.81% | -6.25% | NA | -36.10% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more